NRCAM and colon adenocarcinoma: NRCAM had been proposed in previous studies as an independent marker of poor prognosis in advanced COAD using immunohistochemical experiments and tissue microarrays methods, and its over-expression had been found to inhibit the effect of chemotherapy with 5-fluorouracil.